Clinical Orthopaedics and Related Research®

, Volume 471, Issue 7, pp 2327–2332

The Influence of Botulinum Toxin A Injections into the Calf Muscles on Genu Recurvatum in Children With Cerebral Palsy

  • Matthias C. M. Klotz
  • Sebastian I. Wolf
  • Daniel Heitzmann
  • Simone Gantz
  • Frank Braatz
  • Thomas Dreher
Clinical Research

Abstract

Background

With cerebral palsy (CP), an equinus deformity may lead to genu recurvatum. Botulinum toxin A (BtA) injection into the calf muscles is a well-accepted treatment for dynamic equinus deformity.

Questions/purposes

The purpose of this study was to determine whether BtA injections into the calf muscles to decrease equinus would decrease coexisting genu recurvatum in children with diplegic CP.

Methods

In a retrospective study, 13 children (mean age, 5 years) with spastic diplegic CP showing equinus and coexisting primary genu recurvatum, who were treated with BtA injections into the calf muscles, were included. Evaluations were done before and 6 and 18 weeks after intervention using three-dimensional gait analysis and clinical examinations according to a standardized protocol. Basic statistical analyses (power analysis, ANOVA) were performed to compare genu recurvatum before treatment and at 6 and 18 weeks after injection with BtA.

Results

During stance phase, maximum ankle dorsiflexion was increased substantially from −3.0° ± 14.3° before to 6.2° ± 14.2° 6 weeks after the injections. Despite this, with the numbers available, the amount of recurvatum in stance did not improve with treatment at either 6 or 18 weeks. There was significant improvement of knee hyperextension during stance phase of 6.2° between baseline and 18 weeks after BtA injection, but a genu recurvatum was still present in most patients.

Conclusions

Despite improvement of ankle dorsiflexion after injection with BtA, genu recurvatum did not show relevant improvement at 6 or 18 weeks after injection with the numbers available. Because knee hyperextension remained in most patients, other factors leading to genu recurvatum should be taken into consideration. In addition, a botulinum toxin-induced weakness of the gastrocnemius may explain why recurvatum gait was not significantly reduced.

Level of Evidence

Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

References

  1. 1.
    Aiona MD, Sussman MD. Treatment of spastic diplegia in patients with cerebral palsy: Part II. J Pediatr Orthop B. 2004;13:S13–38.PubMedGoogle Scholar
  2. 2.
    Baddar A, Granata K, Damiano DL, Carmines DV, Blanco JS, Abel MF. Ankle and knee coupling in patients with spastic diplegia: effects of gastrocnemius-soleus lengthening. J Bone Joint Surg Am. 2002;84:736–744.PubMedGoogle Scholar
  3. 3.
    Bang MS, Chung SG, Kim SB, Kim SJ. Change of dynamic gastrocnemius and soleus muscle length after block of spastic calf muscle in cerebral palsy. Am J Phys Med Rehabil. 2002;81:760–764.PubMedCrossRefGoogle Scholar
  4. 4.
    Banks HH. The knee and cerebral palsy. Orthop Clin North Am. 1972;3:113–129.PubMedGoogle Scholar
  5. 5.
    Banks HH. The management of spastic deformities of the foot and ankle. Clin Orthop Relat Res. 1977;122:70–76.PubMedGoogle Scholar
  6. 6.
    Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol. 1994;36:386–396.PubMedCrossRefGoogle Scholar
  7. 7.
    Fry NR, Gough M, McNee AE, Shortland AP. Changes in the volume and length of the medial gastrocnemius after surgical recession in children with spastic diplegic cerebral palsy. J Pediatr Orthop. 2007;27:769–774.PubMedCrossRefGoogle Scholar
  8. 8.
    Graham HK, Aoki KR, Autti-Ramo I, Boyd RN, Delgado MR, Gaebler-Spira DJ, Gormley ME, Guyer BM, Heinen F, Holton AF, Matthews D, Molenaers G, Motta F, Garcia Ruiz PJ, Wissel J. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture. 2000;11:67–79.PubMedCrossRefGoogle Scholar
  9. 9.
    Hayek S, Gershon A, Wientroub S, Yizhar Z. The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy. J Bone Joint Surg Br. 2010;92:1152–1159.PubMedGoogle Scholar
  10. 10.
    Houltram J, Noble I, Boyd RN, Corry I, Flett P, Graham HK. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation. Eur J Neurol. 2001;8(suppl 5):194–202.PubMedCrossRefGoogle Scholar
  11. 11.
    Kadaba MP, Ramakrishnan HK, Wootten ME. Measurement of lower extremity kinematics during level walking. J Orthop Res. 1990;8:383–392.PubMedCrossRefGoogle Scholar
  12. 12.
    Kim K, Shin HI, Kwon BS, Kim SJ, Jung IY, Bang MS. Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial. Dev Med Child Neurol. 2011;53:239–244.PubMedCrossRefGoogle Scholar
  13. 13.
    Koog YH, Min BI. Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic review. Clin Rehabil. 2010;24:685–700.PubMedCrossRefGoogle Scholar
  14. 14.
    Lee CL, Bleck EE. Surgical correction of equinus deformity in cerebral palsy. Dev Med Child Neurol. 1980;22:287–292.PubMedCrossRefGoogle Scholar
  15. 15.
    Liu MQ, Anderson FC, Schwartz MH, Delp SL. Muscle contributions to support and progression over a range of walking speeds. J Biomech. 2008;41:3243–3252.PubMedCrossRefGoogle Scholar
  16. 16.
    Maanum G, Jahnsen R, Stanghelle JK, Sandvik L, Keller A. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial. J Rehabil Med. 2011;43:338–347.PubMedCrossRefGoogle Scholar
  17. 17.
    Metaxiotis D, Siebel A, Doederlein L. Repeated botulinum toxin A injections in the treatment of spastic equinus foot. Clin Orthop Relat Res. 2002;394:177–185.PubMedCrossRefGoogle Scholar
  18. 18.
    Neptune RR, Kautz SA, Zajac FE. Contributions of the individual ankle plantar flexors to support, forward progression and swing initiation during walking. J Biomech. 2001;34:1387–1398.PubMedCrossRefGoogle Scholar
  19. 19.
    Olney BW, Williams PF, Menelaus MB. Treatment of spastic equinus by aponeurosis lengthening. J Pediatr Orthop. 1988;8:422–425.PubMedCrossRefGoogle Scholar
  20. 20.
    Perry J, Hoffer MM, Giovan P, Antonelli D, Greenberg R. Gait analysis of the triceps surae in cerebral palsy: a preoperative and postoperative clinical and electromyographic study. J Bone Joint Surg Am. 1974;56:511–520.PubMedGoogle Scholar
  21. 21.
    Polak F, Morton R, Ward C, Wallace WA, Doderlein L, Siebel A. Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy. Dev Med Child Neurol. 2002;44:551–555.PubMedCrossRefGoogle Scholar
  22. 22.
    Rodda JM, Graham HK, Carson L, Galea MP, Wolfe R. Sagittal gait patterns in spastic diplegia. J Bone Joint Surg Br. 2004;86:251–258.PubMedCrossRefGoogle Scholar
  23. 23.
    Saraph V, Zwick EB, Uitz C, Linhart W, Steinwender G. The Baumann procedure for fixed contracture of the gastrosoleus in cerebral palsy: evaluation of function of the ankle after multilevel surgery. J Bone Joint Surg Br. 2000;82:535–540.PubMedCrossRefGoogle Scholar
  24. 24.
    Simon SR, Deutsch SD, Nuzzo RM, Mansour MJ, Jackson JL, Koskinen M, Rosenthal RK. Genu recurvatum in spastic cerebral palsy: report on findings by gait analysis. J Bone Joint Surg Am. 1978;60:882–894.PubMedGoogle Scholar
  25. 25.
    Steele KM, Seth A, Hicks JL, Schwartz MS, Delp SL. Muscle contributions to support and progression during single-limb stance in crouch gait. J Biomech. 2010;43:2099–2105.PubMedCrossRefGoogle Scholar
  26. 26.
    Sutherland DH, Cooper L, Daniel D. The role of the ankle plantar flexors in normal walking. J Bone Joint Surg Am. 1980;62:354–363.PubMedGoogle Scholar
  27. 27.
    Sutherland DH, Davids JR. Common gait abnormalities of the knee in cerebral palsy. Clin Orthop Relat Res. 1993;288:139–147.PubMedGoogle Scholar
  28. 28.
    Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG. Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy: a 3-dimensional motion analysis study. Gait Posture. 1996;4:269–279.CrossRefGoogle Scholar
  29. 29.
    Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture. 1999;10:1–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Svehlik M, Zwick EB, Steinwender G, Saraph V, Linhart WE. Genu recurvatum in cerebral palsy–part A: influence of dynamic and fixed equinus deformity on the timing of knee recurvatum in children with cerebral palsy. J Pediatr Orthop B. 2010;19:366–372.PubMedCrossRefGoogle Scholar
  31. 31.
    Takahashi S, Shrestha A. The vulpius procedure for correction of equinus deformity in patients with hemiplegia. J Bone Joint Surg Br. 2002;84:978–980.PubMedCrossRefGoogle Scholar
  32. 32.
    Wren TA, Rethlefsen S, Kay RM. Prevalence of specific gait abnormalities in children with cerebral palsy: influence of cerebral palsy subtype, age, and previous surgery. J Pediatr Orthop. 2005;25:79–83.PubMedGoogle Scholar
  33. 33.
    Yngve DA, Chambers C. Vulpius and Z-lengthening. J Pediatr Orthop. 1996;16:759–764.PubMedCrossRefGoogle Scholar
  34. 34.
    Zwick EB, Svehlik M, Steinwender G, Saraph V, Linhart WE. Genu recurvatum in cerebral palsy–part B: hamstrings are abnormally long in children with cerebral palsy showing knee recurvatum. J Pediatr Orthop B. 2010;19:373–378.PubMedCrossRefGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2013

Authors and Affiliations

  • Matthias C. M. Klotz
    • 1
  • Sebastian I. Wolf
    • 1
  • Daniel Heitzmann
    • 1
  • Simone Gantz
    • 1
  • Frank Braatz
    • 1
  • Thomas Dreher
    • 1
  1. 1.Department of Orthopaedic and Trauma SurgeryHeidelberg University ClinicsHeidelbergGermany

Personalised recommendations